ArticleScientific reports2025
Controlling mildew of tobacco leaf by Bacillus amyloliquefaciens ZH-2 and its effect on storage quality of tobacco leaf.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Integrated multi-omics reveals microbial and metabolic mechanisms driving enhanced fermentation quality in cigar tobacco leaves with exogenous additives.Bioresources and bioprocessing · 2026Article
- Microbe-driven flavonoid biotransformation revealed by multi-omics analysis during Hua Feng Dan Yao Mu fermentation.Frontiers in microbiology · 2026Article
- Enhancing tobacco quality through microbial-enzymatic processing: mechanisms, applications, and future perspectives.Frontiers in bioengineering and biotechnology · 2026Review
- Microbiome Migration from Soil to Leaves in Maize and Rice.Microorganisms · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Tobacco mildew is a common fungal disease that reduces tobacco quality, resulting in serious economic losses in the tobacco industry. In this study, the pathogens Aspergillus niger, Aspergillus flavus, and Rhizopus arrhizus were isolated from infected leaves. Furthermore, five plant endophytic bacteria isolated from healthy tobacco leaves were found to possess strong antifungal activity against these pathogens. Among these strains, Bacillus amyloliquefaciens ZH-2 exerted the strongest antagonistic effect against all mildew types (bacteriosphere diameter > 22 mm). The antagonistic action of ZH-2 was further observed using scanning electron microscopy, which revealed signs of contraction, deformation, and dissolution of the treated mycelia compared with that seen in the control group. The ZH-2 strain was found to produce high levels of proteases, chitinases, and β-1,3-glucanase, contributing to its antifungal activity via fungal cell wall rupture. The antifungal activity of ZH-2 was also demonstrated in the application test, as indicated by the significant reduction in mildew disease severity in tobacco leaves treated with this strain. Fermentation tests showed that the quality of ZH-2-treated, solid-state fermented tobacco leaves was superior to that of the control. Specifically, the alkaloid content significantly decreased by 10.62%, whereas the total and reduced sugar contents increased by 12.9 and 55.75%, respectively. Furthermore, macromolecular starch, cellulose, and protein contents significantly decreased by 25.85, 12.77, and 10.04%, respectively. These results indicate that the Bacillus amyloliquefaciens ZH-2 strain is effective against tobacco mildew and can improve tobacco quality upon solid-state fermentation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.